Follow-The-Filings

Security · featured owners

EW Edwards Lifesciences Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 5 Owners
  • Max 3.1%
  • $68M
  • 2 add 1 reduce 1 exit

EW (Edwards Lifesciences Corp.) is held in 5 featured 13F books as of 2026 Q2. David Rolfe - Wedgewood Partners is the largest tracked holder by portfolio weight (3.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.1% (David Rolfe - Wedgewood Partners) · not free-float ownership

  1. David Rolfe reduce 3.1%
  2. Palo Alto Investors 0.42%
  3. Davidson Kempner Capital Mana... add 0.34%
  4. Torray Investment Partners 0.04%
  5. Ron Baron add 0.03%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Davidson Kempner Capital Management 2026 Q2 0.34% Add +873.9% 317,500 $29M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 0.03% Add +457.6% 229,603 $21M history
David Rolfe - Wedgewood Partners 2026 Q2 3.1% Reduce −3.4% 165,208 $15M history
Palo Alto Investors 2026 Q2 0.42% Hold 33,640 $3M history
Torray Investment Partners 2026 Q2 0.04% Hold 2,994 $271K history
Andreas Halvorsen - Viking Global Investors exited 2026 Q2 last 2026 Q1 0.25% Exit −0.25% 1,097,578 $88M history

5 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 3 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 22 rows shown

Filed Form Detail Links
4 Period Sep 13, 2026 Filing Doc
4 Period Sep 11, 2026 Filing Doc
4 Period Sep 11, 2026 · 2 forms Filing Doc
4 Period Aug 31, 2026 Filing Doc
4 Period Aug 28, 2026 Filing Doc
4 Period Aug 26, 2026 · 2 forms Filing Doc
4 Period Aug 11, 2026 Filing Doc
4 Period Jul 30, 2026 Filing Doc
4 Period Jul 28, 2026 Filing Doc
4 Period Jul 27, 2026 Filing Doc
4 Period Jul 11, 2026 Filing Doc
4 Period Jul 10, 2026 Filing Doc
4 Period Jul 9, 2026 Filing Doc
4 Period Jul 7, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jun 17, 2026 Filing Doc
4 Period May 29, 2026 Filing Doc
4 Period May 27, 2026 Filing Doc
4 Period May 22, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period May 11, 2026 · 2 forms Filing Doc

Updated about 13 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6B $5.44B $6.07B
Gross profit $4.62B $4.32B $4.73B
Gross margin * 77.0% 79.5% 78.0%
Net income $1.4B $4.17B $1.07B
Net margin * 23.4% 76.7% 17.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.04B $6.29B $6.74B
Total non-current assets * $5.33B $6.77B $6.96B
Total assets $9.36B $13.06B $13.7B
Total current liabilities $1.2B $1.51B $1.81B
Total non-current liabilities * $1.45B $1.49B $1.55B
Total equity $6.65B $10B $10.34B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.896B $0.542B $1.6B
Cash from investing $0.174B $2.31B -$0.713B
Cash from financing -$711M -$983M -$956.8M
Net change in cash $0.375B $1.91B -$0.119B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders